Namløs, Heidi M.
Skårn, Magne
Ahmed, Deeqa
Grad, Iwona
Andresen, Kim
Kresse, Stine H.
Munthe, Else
Serra, Massimo
Scotlandi, Katia
Llombart-Bosch, Antonio
Myklebost, Ola
Lind, Guro E.
Meza-Zepeda, Leonardo A.
Article History
Received: 21 April 2021
Accepted: 27 January 2022
First Online: 17 February 2022
Declarations
:
: For the human samples, all methods were carried out in accordance with relevant guidelines and regulations. The patients included have diseased, and according to the regulations a consent to use is not required, and the project and the collection of samples were approved by the Ethical Committee of Southern Norway (Project 17866).Xenograft experiments were performed according to protocols approved by the Norwegian Animal Research Authority and the Institutional Animal Care of Valencia University. Animal experiments were followed protocols and guidelines approved by the National Animal Research Authority in compliance with the European Convention of the Protection of Vertebrates Used for Scientific Purposes (approval ID 10175) and were approved by Oslo University Hospital. All methods were performed and reported in accordance with ARRIVE guidelines.
: Not applicable.
: The authors declare that they have no competing interests.